Cancer cells from growing ribociclib-resistant tumors modify the behavior of immune regulating myeloid cells, through production of diverse communications including CSF1, CLCF1, FGF, and TGF family members and interleukins 5/11/12. This evidence concerns the gene IL5 and cancer.